Fact CheckerSign in

NCT06819059Completed

Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease

Safety and Efficacy of Pediatric Cardiac Telerehabilitation in Adolescents With Heart Disease

Source: ClinicalTrials.gov · Last updated 11 Feb 2025

Brief summary (registry, in English)

Cardiac telerehabilitation is a much-needed pediatric therapy; however, a lack of randomized controlled trials has limited the development of and reimbursement for this valuable service. Through this prospective, randomized controlled trial, the investigators aim to demonstrate the safety and efficacy of PCTR in a clinically diverse population of children and adolescents with heart disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
6 Feb 2025
Start date
1 May 2023
Primary completion date
1 Nov 2024
Lead sponsor
Columbia University
NCT number
NCT06819059

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 1 May 2023 to the primary completion date, 1 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Clinical instability as demonstrated by recent medication escalation (within 3 months prior to starting the program)

Other illness

  • Significant arrhythmia or ST segment or T wave abnormalities

Other

  • Hemodynamic instability
  • End-tidal carbon dioxide less than 20 mmHg with exercise, or exercise-induced symptoms that would limit ability to participate in the intervention safely

Who the study is looking for

  • Age 10 -25 yrs
  • Not participating in organized sports of physical fitness programs
  • Able to follow basic directions and express symptoms
  • Dx of pulmonary hypertension, congenital heart disease, and transplant programs
  • Clinically stable as deemed by the referring cardiologist

Age in the registry: 10 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Columbia University Medical Center - New York Presbyterian's Morgan Stanley's Children's Hospital
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.